Valor Intrínseco del S&P y Nasdaq Contáctenos

SciSparc Ltd. SPRC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • IL • USD

SharesGrow Score
31/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

SciSparc Ltd. (SPRC) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Los analistas estiman Beneficio por acción (EPS) de $0.03 y ingresos de $6.97B para el próximo año fiscal.

Historial de Beneficio por acción (EPS): 2024: real $-1.08 vs est $0.03 (no alcanzó -3655%). Precisión del analista: 0%.

Estimaciones de BPA — SPRC

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$1.08 vs Est $0.03 ▼ 102.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

Estimaciones de Ingresos — SPRC

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $0.001B vs Est $6.972B ▼ 533,750.9% off
Revenue Trend
Analysts forecast significant revenue growth ahead.
Contáctenos
🎓
SharesGrow Academia
Aprende a calcular el Valor Intrínseco y encontrar acciones infravaloradas.
Sesiones semanales en vivo
Envíanos un mensaje